Defendants Push For Mediation In Drug Pricing Suit

Law360, New York (August 20, 2007, 12:00 AM EDT) -- Drug makers in the massive antitrust class action over the alleged artificial inflation of the prices of various prescription medications have called for mediation in the case, despite recent criticism from the attorneys general of five states.

AstraZeneca Pharmaceuticals LP said in court documents filed Friday that the U.S. District Court for the District of Massachusetts should use its authority in the multidistrict proceeding to oversee the alternative dispute resolution process for all state cases on a global, national basis, arguing that it would be “in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.